MPP’s License Agreement with AbbVie
§2 License Grant:
AbbVie grants to MPP a non-exclusive, non-transferable license to grant sublicense for the purpose under the agreement in the Field and in the Territory. (“Field” is defined as pediatric treatment or prevention of HIV. “Territory” refers to the countries set forth in exhibit A.)
MPP agrees that it will not itself Exploit the AbbVie Patents in any manner. The grant of the license is solely for the purpose of supplying Licensed Compounds and Licensed Products for ultimate use in Licensed Products used in the Field and in the Territory.